These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38963757)

  • 1. Antimicrobial Delivery Using Metallophore-Responsive Dynamic Nanocarriers.
    Raviranga NGH; Ramström O
    ACS Appl Bio Mater; 2024 Jul; 7(7):4785-4794. PubMed ID: 38963757
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Pinto RM; Monteiro C; Costa Lima SA; Casal S; Van Dijck P; Martins MCL; Nunes C; Reis S
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42329-42343. PubMed ID: 34464076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?
    Nafee N; Gaber DM; Abouelfetouh A; Alseqely M; Empting M; Schneider M
    Int J Nanomedicine; 2024; 19():3861-3890. PubMed ID: 38708178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial, Biofilm Inhibitory and Anti-infective Activity of Metallic Nanoparticles Against Pathogens MRSA and Pseudomonas aeruginosa PA01.
    Aswathanarayan JB; Vittal RR
    Pharm Nanotechnol; 2017; 5(2):148-153. PubMed ID: 28440203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of chitosan-alginate microspheres with high antimicrobial and antibiofilm activity against multi-drug resistant microbial pathogens.
    Thaya R; Vaseeharan B; Sivakamavalli J; Iswarya A; Govindarajan M; Alharbi NS; Kadaikunnan S; Al-Anbr MN; Khaled JM; Benelli G
    Microb Pathog; 2018 Jan; 114():17-24. PubMed ID: 29138082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan coupling makes microbial biofilms susceptible to antibiotics.
    Zhang A; Mu H; Zhang W; Cui G; Zhu J; Duan J
    Sci Rep; 2013 Nov; 3():3364. PubMed ID: 24284335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus.
    Tan H; Peng Z; Li Q; Xu X; Guo S; Tang T
    Biomaterials; 2012 Jan; 33(2):365-77. PubMed ID: 22014946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Prevention of Arthroplasty Infections via Incorporation of Activated AgNbO
    Talebpour C; Fani F; Laliberté-Riverin S; Vaidya R; Salimnia H; Alamdari H; Ouellette M
    ACS Appl Bio Mater; 2024 Jun; 7(6):4039-4050. PubMed ID: 38830835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasmall AgNP-Impregnated Biocompatible Hydrogel with Highly Effective Biofilm Elimination Properties.
    Haidari H; Kopecki Z; Bright R; Cowin AJ; Garg S; Goswami N; Vasilev K
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41011-41025. PubMed ID: 32840353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of chitosan oligosaccharide-capped gold nanoparticles as an effective antibiofilm drug against the Pseudomonas aeruginosa PAO1.
    Khan F; Lee JW; Manivasagan P; Pham DTN; Oh J; Kim YM
    Microb Pathog; 2019 Oct; 135():103623. PubMed ID: 31325574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
    Shaaban MI; Shaker MA; Mady FM
    J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Alkylidene-γ-lactones and isobutylpyrrol-2(5H)-ones analogues to rubrolides as inhibitors of biofilm formation by gram-positive and gram-negative bacteria.
    Pereira UA; Barbosa LC; Maltha CR; Demuner AJ; Masood MA; Pimenta AL
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1052-6. PubMed ID: 24484899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of lipo-cyclic γ-AApeptides against biofilms of Staphylococcus epidermidis and Pseudomonas aeruginosa.
    Padhee S; Li Y; Cai J
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2565-9. PubMed ID: 25977094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-induced Synergy for Extended Antimicrobial Potency and Enhanced In Vitro Drug Release of Free Base Ciprofloxacin Nanoplexes.
    Abioye A; Sanyaolu A; Dudzinska P; Adepoju-Bello AA; Coker HAB
    Pharm Nanotechnol; 2020; 8(1):33-53. PubMed ID: 31642799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferulic acid encapsulated chitosan-tripolyphosphate nanoparticles attenuate quorum sensing regulated virulence and biofilm formation in
    Pattnaik S; Barik S; Muralitharan G; Busi S
    IET Nanobiotechnol; 2018 Dec; 12(8):1056-1061. PubMed ID: 30964013
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
    Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
    J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
    Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
    Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.